Endocrine Functions of the Kidney
From pEx
Vitamin D[edit]
- Vitamin D is inactive, and the activation process begins in the liver and ends in the proximal tubular cells within the kidneys with hydroxylation via the 1α-hydroxylase enzyme
- Because of this, the kidneys are major regulators of calcium homeostasis in the GI tract and bone as well as regulators via urinary excretion
- Vitamin D stimulates active absorption of calcium and phosphate by the intestine
- Decreased gut calcium absorption causes decreased availability of calcium for bone formation or reformation. This causes rickets in children.
- It also stimulates renal-tubular reabsorption of calcium and phospate, although this is much less important than the GI effects
- Low calcium causes PTH secretion - secondary hyperparathyroidism, causing:
- Rapid effects: increased renal calcium absorption, increased bone membrane release
- Slow effects: Increased osteoclastic bone resorption and increased 1,25 OH Vit D causing increased Ca absorption
- Hyperphosphataemia occurs almost always in renal failure due to loss of nephrons to excrete phosphate
The Renin-Angiotensin System[edit]
- Renin - an acid protease secreted by the the JG cells of the kidneys into the bloodstream, converting angiotensinogen (produced in liver) to angiotensin I
- Circulating level of angiotensinogen is increased by glucocorticoids, thyroid hormones, estrogens, cytokines and angiotensin II
- Angiotensin I is then converted to angiotensin II by ACE (angiotensin-converting enzyme)
- Most ACE is found in endothelial cells
- ACE also inactivates bradykinin. Increased bradykinin produced when ACE is inhibited
- Angiotensin II is a glycoprotein made up of 2 lobes with a deep active site in the middle
- Angiotensin II is rapidly metabolized, with a circulating half-life of 1-2mins. It is metabolized by various peptidases.
- Angiotensin-metabolising activity is found in red cells and many tissues including the lungs
- Actions of Angiotensin II:
- Angiotensin II causes arteriolar constriction and a rise in systolic and diastolic blood pressure, and is one of the most potent vasoconstrictors known - 4 to 8x more potent than noradrenaline
- Its pressor activity is decreased in patients with cirrhosis and Na+ depletion due to downregulation of angiotensin receptors on vascular smooth muscle
- Angiotensin II also acts on adrenal cortex to increase secretion of aldosterone
- Angiotensin II also facilitates:
- Noradrenaline release by direct action on post-ganglionic sympathetic neurons
- Contraction of mesangial cells to decrease GFR
- Increases Na+ reabsorption by direct effect on renal tubules
- Acts on brain to decrease baroreflex sensitivity, potentiating the pressor effect of angiotensin II
- Acts on the brain to increase water intake via thirst, and increase vasopressin and ACTH secretion
- Many tissues have components of the renin-angiotensin system in them, and it may be involved as a growth factor in vessels and heart
- Angiotensin II receptors:
- AT1 - serpentine G protein coupled receptors which increase cytosolic free Ca2+ levels causing vasoconstriction
- AT2 - act via G proteins which act via phosphatases to antagonise growth effects and open K+ channels
- Also cause increased production of NO and therefore cGMP
- The Juxtaglomerular Apparatus is made up of juxtaglomerular cells, macula densa and lacis cells. JG cells are the site of renin production.
- Renin secretion is determined by:
- Intra-renal baroreceptor mechanism which causes decreased renin secretion when arteriolar pressure in the JG cells increases
- Macula densa sensing Na+ and Cl- entering the distal renal tubules in the loop of Henle
- Direct feedback on JG cells by angiotensin II
- Increased sympathetic nervous system activity increases renin secretion
- Conditions leading to renin secretion include: Na+ depletion, diuretics, hypotension, haaemorrhage, dehydration, upright posture, cardiac failure, cirrhosis
Erythropoietin[edit]
- Increases production of red blood cells from bone marrow
- 85% produced in kidneys, 15% in liver. The liver cannot compensate enough when renal production is lost, and anaemia develops
- Produced by interstitial cells in the peritubular capillary bed of the kidneys and by perivenous hepatocytes
- Recombinant EPO given to renal failure patients, as well as to stimulate red cell production in individuals banking autologous transfusions during elective surgery
- Secretion is regulated by hypoxia acting on heme protein in liver which activates the EPO gene in its reduced form